510(k) Report

510(k) · Cleared

Cleared

NOVA Lite DAPI ANA Kit

K150155510(k) TraditionalCleared Apr 8, 201575-day reviewClass II21 CFR 866.5100

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Inova Diagnostics, Inc. · DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control

Cleared on Apr 8, 2015 as substantially equivalent to K880736 (Inova Diagnostics, Inc., 1988) after a 75-day review. Its family tree reaches back 1 generation to 1988.

Decided
Apr 8, 2015
Review
75 days
Class
Class II
Product code
DHN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K880736 (1988). No later device cites it as a predicate yet.

K880736 · Nova Lite (TM) Ana · Inova Diagnostics, Inc. · 19881985199019952000200520102015
K880736 · Nova Lite (TM) Ana · Inova Diagnostics, Inc. · 19880
  1. Root · 1 generation backK880736 Nova Lite (TM) AnaInova Diagnostics, Inc. · 1988
  2. This deviceK150155 NOVA Lite DAPI ANA KitInova Diagnostics, Inc. · 2015
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K880736Nova Lite (TM) AnaInova Diagnostics, Inc.1988—
0 (this device)K150155NOVA Lite DAPI ANA KitInova Diagnostics, Inc.2015—
FIG. 1 — Lineage of K150155, 1988–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DHN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K880736Nova Lite (TM) Ana
Summary page 8
…Page 5 of 27 8. Indications for Use Same as intended use. 9. Predicate device NOVA Lite HEp-2 ANA Kit, 510k number: k880736 10. Comparison matrix to predicate device Item NOVA Lite DAPI ANA Kit Predicate Device…
Inova Diagnostics, Inc.1988—

Also cleared against K880736: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K880736.

How does its category compare?

All DHN devices

DHN Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · DHN

1in 2022

2007: 12012: 12014: 12015: 22016: 22018: 12022: 1
2007high 2 (2015) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DHN

Too few DHN 510(k)s in any year since 2007 to give a median.

Recalls per year · DHN

1in 2011

2008: 22010: 12011: 1
2007high 2 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DHN

No MAUDE report names DHN since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—20
20090—00
20100—10
20110—10
20121—00
20130—00
20141—00
20152—00
20162—00
20170—00
20181—00
20190—00
20200—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

NOVA Lite® DAPI ANA Kit is an indirect immunofluorescence assay for the qualitative detection and semi-quantitative determination of anti-nuclear antibodies of the IgG isotype in human serum by manual fluorescence microscopy or with the NOVA View Automated Fluorescence Microscope. The presence of anti-nuclear antibodies can be used in conjunction with other serological tests and clinical findings to aid in the diagnosis of systemic lupus erythematosus and other systemic rheumatic diseases. A trained operator must confirm results when generated with the NOVA View device.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K150155: NOVA Lite DAPI ANA Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K150155

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026